Package 16729-151-31

Brand: topotecan hydrochloride

Generic: topotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 16729-151-31
Digits Only 1672915131
Product NDC 16729-151
Product ID 16729-151_23a75b4a-a836-a01d-e063-6394a90a67b3
Description

1 VIAL in 1 PACKAGE (16729-151-31) / 4 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2013-07-23
Brand topotecan hydrochloride
Generic topotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

topotecan hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "23a75b4a-a836-a01d-e063-6394a90a67b3", "openfda": {"upc": ["0316729151313"], "unii": ["956S425ZCY"], "rxcui": ["1799416"], "spl_set_id": ["729b2b22-1344-44f3-b614-14f6ec3c263e"], "manufacturer_name": ["Accord Healthcare, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 PACKAGE (16729-151-31)  / 4 mL in 1 VIAL", "package_ndc": "16729-151-31", "marketing_start_date": "20130723"}], "brand_name": "topotecan hydrochloride", "product_id": "16729-151_23a75b4a-a836-a01d-e063-6394a90a67b3", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "16729-151", "generic_name": "topotecan hydrochloride", "labeler_name": "Accord Healthcare, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "topotecan hydrochloride", "active_ingredients": [{"name": "TOPOTECAN HYDROCHLORIDE", "strength": "4 mg/4mL"}], "application_number": "ANDA202351", "marketing_category": "ANDA", "marketing_start_date": "20130723", "listing_expiration_date": "20261231"}